Canaccord Downgrades Medicis to Hold

Symbols: MRX
Share

Canaccord Genuity has downgraded Medicis Pharmaceutical Corporation (NYSE: MRX) from Buy to Hold and has lowered the price target from $38 to $36.


 
 
< Previous
Bank of America Downgrades AmeriGas Partners to Underperform
Next >
Sterne Agee Downgrades Reinsurance Group of America to Neutral
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust